Robert Kalb, MD, has been named to lead the Les Turner ALS Research and Patient Center at Northwestern Medicine, as the center’s inaugural director.
A study has identified a new mechanism for how a gene mutation leads to the death of neurons in amyotrophic lateral sclerosis and a related form of dementia.
A study published in Neuron suggests the brain’s own compensatory mechanisms contribute to the debilitating motor symptoms of Parkinson’s disease.
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
Northwestern Medicine scientists have demonstrated a new method that helps to pinpoint which genetic variants might be most important in the development of schizophrenia and related disorders.
A new study published in Nature Communications finds that practicing generosity activates an area of the brain associated with reward and happiness.
Kritika Nayar, a fourth-year student in the Clinical Psychology PhD Program, studies visual perception and its role in autism spectrum disorder in the laboratory of Molly Losh, PhD, associate professor of Psychiatry and Behavioral Sciences.
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
Dane Chetkovich, MD, PhD, professor of Neurology and director of the Medical Scientist Training Program, will be chair of Neurology at Vanderbilt University Medical Center.
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.